Hydralazine Hydrochloride Tablet
Product Images NDC 55154-0187

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 55154-0187). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50mg Bag Label (336b11da E592 4386 921f 3c136d754f2a 00)

FDA Label Image

25mg Bag Label (336b11da E592 4386 921f 3c136d754f2a 01)

25mg Bag Label (336b11da E592 4386 921f 3c136d754f2a 01)
This text provides information about HydrALAZINE Hydrochloride tablets, USP, with a strength of 25mg per tablet. It includes dosage instructions, storage guidelines, manufacturer details, and a warning about child-resistant packaging. The medication is distributed by Major Pharmaceuticals and Avet Pharmaceuticals Inc. It is essential to refer to the product insert for complete prescribing information, precautions, and warnings. Storage temperature should be between 20°C to 25°C.*
FDA Label Image
FDA Label Image

Chemical-structure (Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.